Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIGEN-BINDING MOLECULES CAPABLE OF BINDING CD3 AND CD137 BUT NOT SIMULTANEOUSLY
Document Type and Number:
WIPO Patent Application WO/2020/067419
Kind Code:
A1
Abstract:
The present invention relates to antigen-binding molecules binding to CD3 and CD137 (4-1BB); compositions comprising the antigen-binding molecule; and methods of using the same. The present invention provides antigen-binding molecules comprising: an antibody variable region that is capable of binding to CD3 and CD137 (4-1BB), but does not bind to CD3 and CD137 at the same time; and a variable region binding to a third antigen different from CD3 and CD137. Such antigen binding molecules exhibit enhanced T-cell dependent cytotoxity activity induced by these antigen-binding molecules through binding to the three different antigens.

Inventors:
HO SHU WEN SAMANTHA (SG)
FENG SHU (SG)
Application Number:
PCT/JP2019/038138
Publication Date:
April 02, 2020
Filing Date:
September 27, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHUGAI PHARMACEUTICAL CO LTD (JP)
International Classes:
C07K16/28; C07K16/30; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13; C12P21/08
Domestic Patent References:
WO2019111871A12019-06-13
Foreign References:
EP3070168A12016-09-21
EP3219724A12017-09-20
EP3130606A12017-02-15
Other References:
See also references of EP 3856785A4
Attorney, Agent or Firm:
HARUNA, Masao et al. (JP)
Download PDF: